VTGN logo

VistaGen Therapeutics (VTGN) Cash And Cash Equivalents

Annual Cash & Cash Equivalents

$119.17 M
+$102.53 M+616.23%

March 31, 2024


Summary


Performance

VTGN Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherVTGNbalance sheetmetrics:

Quarterly Cash And Cash Equivalents

$84.25 M
-$18.67 M-18.14%

September 30, 2024


Summary


Performance

VTGN Quarterly Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherVTGNbalance sheetmetrics:

Cash And Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

VTGN Cash And Cash Equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+616.2%0.0%
3 y3 years+15.6%0.0%
5 y5 years+809.6%0.0%

VTGN Cash And Cash Equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+616.2%-33.4%+775.5%
5 y5-yearat high+8693.9%-33.4%+7823.1%
alltimeall timeat high-100.0%-33.4%-100.0%

VistaGen Therapeutics Cash And Cash Equivalents History

DateAnnualQuarterly
Sep 2024
-
$84.25 M(-18.1%)
Jun 2024
-
$102.92 M(-13.6%)
Mar 2024
$119.17 M(+616.2%)
$119.17 M(-5.8%)
Dec 2023
-
$126.56 M(+236.5%)
Sep 2023
-
$37.61 M(+290.8%)
Jun 2023
-
$9.62 M(-42.2%)
Mar 2023
$16.64 M(-75.6%)
$16.64 M(-33.5%)
Dec 2022
-
$25.04 M(-29.0%)
Sep 2022
-
$35.29 M(-32.1%)
Jun 2022
-
$51.99 M(-23.7%)
Mar 2022
$68.14 M(-33.9%)
$68.14 M(-18.6%)
Dec 2021
-
$83.70 M(-10.6%)
Sep 2021
-
$93.63 M(-4.2%)
Jun 2021
-
$97.78 M(-5.2%)
Mar 2021
$103.11 M(+7508.9%)
$103.11 M(-1.2%)
Dec 2020
-
$104.33 M(+577.5%)
Sep 2020
-
$15.40 M(+896.2%)
Jun 2020
-
$1.55 M(+14.1%)
Mar 2020
$1.36 M(-89.7%)
$1.36 M(+27.4%)
Dec 2019
-
$1.06 M(-73.9%)
Sep 2019
-
$4.07 M(-50.9%)
Jun 2019
-
$8.30 M(-36.7%)
Mar 2019
$13.10 M(+26.2%)
$13.10 M(+108.4%)
Dec 2018
-
$6.29 M(-19.7%)
Sep 2018
-
$7.83 M(+8.3%)
Jun 2018
-
$7.23 M(-30.3%)
Mar 2018
$10.38 M(+255.3%)
$10.38 M(-20.4%)
Dec 2017
-
$13.03 M(+638.6%)
Sep 2017
-
$1.76 M(+8.4%)
Jun 2017
-
$1.63 M(-44.3%)
Mar 2017
$2.92 M
$2.92 M(-33.2%)
Dec 2016
-
$4.37 M(-30.1%)
DateAnnualQuarterly
Sep 2016
-
$6.26 M(-26.4%)
Jun 2016
-
$8.50 M(+1883.6%)
Mar 2016
$428.50 K(+512.1%)
$428.50 K(-63.0%)
Dec 2015
-
$1.16 M(+66.9%)
Sep 2015
-
$694.00 K(+473.6%)
Jun 2015
-
$121.00 K(+72.9%)
Mar 2015
$70.00 K(>+9900.0%)
$70.00 K(+430.3%)
Dec 2014
-
$13.20 K(>+9900.0%)
Sep 2014
-
$0.00(-100.0%)
Jun 2014
-
$400.70 K(>+9900.0%)
Mar 2014
$0.00(-100.0%)
$0.00(-100.0%)
Dec 2013
-
$20.70 K(+218.5%)
Sep 2013
-
$6500.00(-92.8%)
Jun 2013
-
$89.80 K(-85.9%)
Mar 2013
$638.10 K(+687.8%)
$638.10 K(+2536.8%)
Dec 2012
-
$24.20 K(+80.6%)
Sep 2012
-
$13.40 K(-57.7%)
Jun 2012
-
$31.70 K(-60.9%)
Mar 2012
$81.00 K(+4400.0%)
$81.00 K(-51.3%)
Dec 2011
-
$166.40 K(+76.1%)
Sep 2011
-
$94.50 K(-90.0%)
Jun 2011
-
$942.10 K(>+9900.0%)
Mar 2011
-
$6100.00(+238.9%)
Dec 2010
$1800.00(+200.0%)
$1800.00(-21.7%)
Sep 2010
-
$2300.00(+21.1%)
Jun 2010
-
$1900.00(-45.7%)
Mar 2010
-
$3500.00(+483.3%)
Dec 2009
$600.00(-97.2%)
$600.00(-80.0%)
Sep 2009
-
$3000.00(+100.0%)
Jun 2009
-
$1500.00(-93.1%)
Dec 2008
$21.80 K
$21.80 K(>+9900.0%)
Jun 2008
-
$200.00(-33.3%)
Mar 2008
-
$300.00

FAQ

  • What is VistaGen Therapeutics annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for VistaGen Therapeutics?
  • What is VistaGen Therapeutics annual cash & cash equivalents year-on-year change?
  • What is VistaGen Therapeutics quarterly cash and cash equivalents?
  • What is the all time high quarterly cash and cash equivalents for VistaGen Therapeutics?
  • What is VistaGen Therapeutics quarterly cash and cash equivalents year-on-year change?

What is VistaGen Therapeutics annual cash & cash equivalents?

The current annual cash & cash equivalents of VTGN is $119.17 M

What is the all time high annual cash & cash equivalents for VistaGen Therapeutics?

VistaGen Therapeutics all-time high annual cash & cash equivalents is $119.17 M

What is VistaGen Therapeutics annual cash & cash equivalents year-on-year change?

Over the past year, VTGN annual cash & cash equivalents has changed by +$102.53 M (+616.23%)

What is VistaGen Therapeutics quarterly cash and cash equivalents?

The current quarterly cash and cash equivalents of VTGN is $84.25 M

What is the all time high quarterly cash and cash equivalents for VistaGen Therapeutics?

VistaGen Therapeutics all-time high quarterly cash and cash equivalents is $126.56 M

What is VistaGen Therapeutics quarterly cash and cash equivalents year-on-year change?

Over the past year, VTGN quarterly cash and cash equivalents has changed by $0.00 (0.00%)